Concept for feasibility review
Calcium, Magnesium & Zinc with Vitamin D3
TabletJoint & Bone Health
Concept status
Preliminary Calcium, Magnesium & Zinc with Vitamin D3 tablet concept for project-specific commercial and regulatory feasibility review. This is not a licensed, approved, or ready-to-order Canadian product.
Preliminary source ingredients
Each tablet contains: • Vitamin D3 (as D3 333.33 IU) …… 8 µg (mcg) • Calcium Citrate …… 500 mg • Magnesium Oxide …… 250 mg • Zinc Sulfate …… 12.5 mg • Cupric Sulphate …… 0.833 mg • Manganese Sulphate …… 4.2 mg Other Ingredients: Starch, Croscarmellose Sodium, Microcrystalline Cellulose, Magnesium Stearate, Colloidal Silicon Dioxide, Purified Talc.
Directions status
No Canadian directions for use have been established.
Directions and dosing are not established. They require formula, monograph, evidence, population, risk, and label review for the specific project.
Market assessment status
No public market-equivalence assessment has been completed for this preliminary concept.
Assess this concept for your project
Tell us your market, target format, quantities, timing, and current regulatory status. We will scope the commercial and regulatory feasibility review.